16 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
and in January 2024, additional
- 13 - complaints were filed in the U.S. District Court for the District of Massachusetts by a health insurer plaintiff
F-3ASR
EX-1.1
lipvn6a 8h1
24 Jun 20
Automatic shelf registration (foreign)
4:30pm
20-F
zak4ythnl1jik
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
lod4rtpqxl98r
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.1
4h9l0e
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.13
ssu 8js6i1l
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
CORRESP
3my6xf1tfxa2oxm6v
17 Dec 18
Correspondence with SEC
12:00am
20FR12B
EX-10.1
r7gizjf
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B
EX-10.13
73d ek5uj
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
EX-10.1
bwde2h82c2z 5b8129
16 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next